Xperi (XPER) PT Lowered to $20 at RBC Capital
Tweet
Share
E-mailGet Alerts XPER Hot Sheet
Price: $6.59 -0.45%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
RBC Capital analyst Amit Daryanani lowered the price target on Xperi (NASDAQ: XPER) to $20.00 (from $22.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Siloam International Hospitals Tbk PT (SILO:IJ) PT Lowered to IDR3,000 at Macquarie
- Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
